Ketamine as augmentation for the treatment of major depression and suicidal risk in advanced cancer: case report - Rodr íguez-Mayoral O, Pérez-Esparza R, Domínguez-Ocadio G, Allende-Pérez S.

OBJECTIVE: Major depressive disorder (MDD) is common in patients diagnosed with advanced cancer (AC), with a prevalence of 16.5%. It is associated with great disability and worsened quality of life, increased number and intensity of physical symptoms, and ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news